文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
A phase III study (COSMIC-313) of cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in patients (pts) with previously untreated advanced renal cell carcinoma (aRCC) of intermediate or poor risk.
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
R. Motzer
|
T. Powles
|
T. Choueiri
|
L. Albiges
|
C. Scheffold
|
Fong Wang
保存到论文桶